Solid Therapeutics

Copenhagen, Denmark

Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.

Sep 2023

Convertible Note

Biotechnology Health Care Medical Oncology Therapeutics

Top Investors

BioInnovation Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Solid Therapeutics

Who are Solid Therapeutics's investors?

Solid Therapeutics's investors include BioInnovation Institute.

Where is Solid Therapeutics headquartered?

Solid Therapeutics is headquartered in Copenhagen, Denmark.

What does Solid Therapeutics do?

Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.

What stage is Solid Therapeutics at?

Solid Therapeutics is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2023.

MLA

"Solid Therapeutics — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/solid-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Solid Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/solid-therapeutics

Wikipedia (cite web)

{{cite web |title=Solid Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/solid-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K